Skip to the page

Data / Form D filings / Eugene Health, Inc.

Eugene Health, Inc.: Form D filing

Eugene Health, Inc., a technology company in New York, NY, filed a Form D with the SEC in 2024. The latest, on July 25, 2024, reports $5.3 million sold of a $21.3 million offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
C/O EUGENE HEALTH, INC., 386 PARK AVE S. - 14TH FLOOR, New York, NY, 10016
Phone
(000) 000-0000
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2031372

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 25, 2024New notice$21,250,000$5,250,000$16,000,0005Jul 10, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Word PeakeDirector
Eric BeckDirector
Jonathan CollinsExecutive Officer, Director
Sam TooleDirector

Other technology companies in New York that filed recently

Every Form D from the week of Jul 22, 2024 · All recent filings in New York · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Eugene Health, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.